Meanwhile,xanthine oxidase (XO) represents another source of ROS in hypertension, which hasbeen historically suggested and trialed as a target therapeutic approach inhypertension [43]; however, the results were inconsistent, and there were adverseeffects associated with the treatment [55]. This evidence concerns the gene XDH and Hypertension.